STERIS plc Goodwill, Impairment Loss
STERIS plc (STE) reported Goodwill, Impairment Loss of $0 for the 12-month period ending 2025-03-31, per its 10-K filed 2025-05-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GoodwillImpairmentLoss · last filed 2025-05-29
- STERIS plc goodwill, impairment loss for the quarter ending 2024-03-31 was $0.00.
- STERIS plc goodwill, impairment loss for the quarter ending 2023-12-31 was $0.00.
- STERIS plc goodwill, impairment loss for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- STERIS plc goodwill, impairment loss for the quarter ending 2023-03-31 was $0.00.
- STERIS plc goodwill, impairment loss for fiscal 2025 was $0.00.
- STERIS plc goodwill, impairment loss for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- STERIS plc goodwill, impairment loss for fiscal 2023 was $490.56M.
- STERIS plc goodwill, impairment loss for fiscal 2022 was $0.00.
| Period end | Goodwill, Impairment Loss 3 month | Goodwill, Impairment Loss 6 month | Goodwill, Impairment Loss 9 month | Goodwill, Impairment Loss 12 month |
|---|---|---|---|---|
| 2025-03-31 | $0.00 10-K · filed 2025-05-29 | |||
| 2024-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | $0.00 derived: sum of 2 quarters · filed 2025-05-29 | $0.00 derived: sum of 3 quarters · filed 2025-05-29 | $0.00 10-K · filed 2025-05-29 |
| 2023-12-31 | $0.00 10-Q · filed 2024-02-08 | $0.00 derived: sum of 2 quarters · filed 2024-02-08 | $0.00 10-Q · filed 2024-02-08 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | ||
| 2023-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | $0.00 derived: sum of 2 quarters · filed 2025-05-29 | $490.56M derived: sum of 3 quarters · filed 2025-05-29 | $490.56M 10-K · filed 2025-05-29 |
| 2022-12-31 | $0.00 10-Q · filed 2024-02-08 | $490.56M derived: sum of 2 quarters · filed 2024-02-08 | $490.56M 10-Q · filed 2024-02-08 | |
| 2022-09-30 | $490.56M 10-Q · filed 2023-11-07 | $490.56M 10-Q · filed 2023-11-07 | ||
| 2022-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-29 | $0.00 derived: sum of 2 quarters · filed 2024-05-29 | $0.00 derived: sum of 3 quarters · filed 2024-05-29 | $0.00 10-K · filed 2024-05-29 |
| 2021-12-31 | $0.00 10-Q · filed 2023-02-08 | $0.00 derived: sum of 2 quarters · filed 2023-02-08 | $0.00 10-Q · filed 2023-02-08 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | ||
| 2021-03-31 | $0.00 10-K · filed 2023-05-26 | |||
| 2019-03-31 | $0.00 10-K · filed 2019-05-30 | |||
| 2018-03-31 | $0.00 10-K · filed 2019-05-30 | |||
| 2017-03-31 | $58.36M 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |